$KLAC

Higgins Bren D. sold $6.6M of KLAC

Higgins Bren D. (EVP & Chief Financial Officer) sold 31,500 shares of KLA CORP (KLAC) at $209.87 ($6.61M total) on 2026-08-12 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Higgins Bren D.
Published Aug 13, 2026, 8:05 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 13, 2026, 8:10 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$KLAC
Neutral
high confidence
Mentioned
$KLAC
Relevance
5/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$KLACNeutralLow
01

Why it matters

The filing provides transparency on insider selling activity but does not include new operational, financial, or regulatory information about KLA.

02

Market read

Traders may note insider selling, but the 10b5-1 designation makes it less likely to be a strong standalone catalyst.

03

What to watch

10b5-1 plans can span multiple trades and dates, so a single Form 4 snapshot may not represent the insider’s current view.

Relevance 5/10Novelty 3/10Timing: filed 2026-08-13 after-hours; transaction dated 2026-08-12

Background

The article is a SEC Form 4 insider transaction disclosure for KLA Corp (KLAC).

Company-level read

Ticker impact

$KLACNeutralHigh confidence
Context

KLA CFO Higgins Bren D. sold 31,500 shares on 2026-08-12 under a 10b5-1 plan, worth about $6.61M.

Expected impact

Low likelihood of a sustained price move from this filing alone; any reaction is likely short-lived.

Evidence & confidence

Form 4 discloses the transaction size and that it was executed under a pre-arranged 10b5-1 plan, which typically reduces interpretive value versus discretionary selling.

Market effects

Minimal; insider sales at a single large-cap semiconductor equipment name rarely reset sector expectations.

None indicated.

None indicated.

Counterpoint

The sale could reflect liquidity needs or diversification rather than bearish expectations, especially given the stated 10b5-1 plan.

Key entities

  • KLA Corp

    Subject of the Form 4 insider transaction disclosure.

  • Higgins Bren D.

    EVP and Chief Financial Officer who sold shares.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$ACMRMed

AI Sovereignty Becomes a New National Security Battleground: Morgan Stanley Names SpaceX and 4 Other Beneficiary Stocks, with Upside Potential Topping 100% — BigGo Finance

Morgan Stanley identifies SpaceX, ACM Research, Amkor Technology, Alibaba, and KLA as key beneficiaries of the AI sovereignty trend. The bank assigns price targets with upside potential ranging from 21% to 105%, highlighting the strategic importance of AI infrastructure for national security and economic competitiveness.

$KLACMedAI 8/10

KLA Gains From Advanced Packaging: Can it Outpace ONTO & AMAT?

KLA (KLAC) is seeing growth in advanced packaging due to AI and HPC chip demand, expecting $1.1B in 2026 revenue. Competitors Onto Innovation (ONTO) and Applied Materials (AMAT) are also expanding in this sector. KLAC's stock is up 50.9% YTD, with a forward P/S of 13.05X. Analysts estimate 2027 earnings at $5.43 per share, up 7.1% in 30 days.

$KLACHighAI 8/10

Is Wall Street Bullish or Bearish on KLA Corporation Stock?

KLA Corporation (KLAC) reported strong Q4 2026 results with revenue up 15.1% to $3.66B and adjusted EPS of $1.05, beating estimates. The company's Q1 2027 guidance also exceeded consensus. Shares have surged 110.9% over 52 weeks, outperforming the S&P 500. Analysts expect 44.2% EPS growth for FY 2027, with a consensus 'Moderate Buy' rating and a mean price target of $237.81.

$KLACHighAI 9/10

KLA Corporation: See What Wall Street Sees

KLA Corporation (KLAC) dropped 14% in a month despite strong market position and raised revenue guidance. The company reported Q4 revenue of $3.66B, up 15% YoY, and raised its 2026 outlook. CEO Rick Wallace sold 87,568 shares. The stock trades at a 34 forward P/E, with concerns around China export controls and insider sales.

$KLACMed

Can KLA's Advanced Packaging Strength Support $1B Revenue Target?

KLA (KLAC) says advanced packaging revenues in its semiconductor process control portfolio should rise to nearly $1B in 2026 from about $635M in 2025, citing stronger customer demand. The company reported advanced wafer-level packaging revenue up nearly 70% YoY in 2025 and expects growth weighted to H2 2026, supported by AI-driven semiconductor complexity and CoWoS/SoIC demand.

$AMATMed

Applied Materials is Down 6% Premarket. Will It Drag Down Lam Research, KLA, and Other Semi Equipment Stocks?

Applied Materials (AMAT) fell about 5.7% premarket after record fiscal Q3 results but guidance for Q4 revenue and margins missed elevated expectations. The company reported record Q3 revenue of $9.1B and non-GAAP EPS of $3.50, and guided Q4 revenue to $10.25B plus or minus $500M and EPS to $4.02 plus or minus $0.20. Lam Research (LRCX) and KLA (KLAC) were little changed premarket.